Pure and Mixed Mucinous Carcinoma of the Breast: A Comparison of Clinical Outcomes and Treatment Results
Mucinous carcinoma
Breast carcinoma
DOI:
10.1111/tbj.12621
Publication Date:
2016-06-04T05:22:42Z
AUTHORS (7)
ABSTRACT
Mucinous breast carcinoma (MBC) represents approximately 1–6% of all malignant and is divided into pure (PMBC) mixed (MMBC) subtypes. This study presents the comparison clinical characteristics treatment results in 70 patients with PMBC 40 MMBC, treated at a single institution during 25 years. Performed analyses showed that only nodal status was different both Patients MMBC significantly higher incidence axillary metastases to (25% versus 10%, respectively). Instead, 10-year disease-free survival rate significant than (85.7% 65%, p < 0.02, test log rank). Authors own observations data from literature proved should be considered as subtypes mucinous cancer.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (37)
CITATIONS (36)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....